Pharmaceuticals

China Pharmerging Market Research Report 2017

  • QYR1043777
  • 109 Pages
  • March 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Pharmerging

Revenue, means the sales value of Pharmerging

This report studies Pharmerging in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering

AstraZeneca

GlaxoSmithKline

Pfizer

Sanofi

Novartis

Abbott Laboratories

Shire

Bayer

Biogen

F. Hoffmann-La Roche

Johnson & Johnson

Mitsubishi Tanabe Pharma

Novo Nordisk

Sun Pharmaceutical

Takeda Pharma

Teva Pharmaceutical Industries

Market Segment by Regions (provinces), covering

South China

East China

Southwest China

Northeast China

North China

Central China

Northwest China

Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into

Tier 1

Tier 2

Tier 3

Split by Application, this report focuses on consumption, market share and growth rate of Pharmerging in each application, can be divided into

Lung Cancer

Breast Cancer

Chronic Myeloid Leukemia

Lymphomas

Other

Table of Contents

China Pharmerging Market Research Report 2017

1 Pharmerging Market Overview

1.1 Product Overview and Scope of Pharmerging

1.2 Pharmerging Segment by Type

1.2.1 China Production Market Share of Pharmerging Type in 2015

1.2.2 Tier 1

1.2.3 Tier 2

1.2.4 Tier 3

1.3 Applications of Pharmerging

1.3.1 Pharmerging Consumption Market Share by Application in 2015

1.3.2 Lung Cancer

1.3.3 Breast Cancer

1.3.4 Chronic Myeloid Leukemia

1.3.5 Lymphomas

1.3.6 Other

1.4 China Market Size (Value) of Pharmerging (2012-2022)

1.5 China Pharmerging Status and Outlook

1.6 Government Policies

2 China Pharmerging Market Competition by Manufacturers

2.1 China Pharmerging Capacity, Production and Share by Manufacturers (2015 and 2016)

2.2 China Pharmerging Revenue and Share by Manufacturers (2015 and 2016)

2.3 China Pharmerging Average Price by Manufacturers (2015 and 2016)

2.4 Manufacturers Pharmerging Manufacturing Base Distribution, Sales Area, Product Type

2.5 Pharmerging Market Competitive Situation and Trends

2.5.1 Pharmerging Market Concentration Rate

2.5.2 Pharmerging Market Share of Top 3 and Top 5 Manufacturers

3 China Pharmerging Manufacturers Profiles/Analysis

3.1 AstraZeneca

3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.1.2 Pharmerging Product Type, Application and Specification

3.1.2.1 Product A

3.1.2.2 Product B

3.1.3 AstraZeneca Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.1.4 Main Business/Business Overview

3.2 GlaxoSmithKline

3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.2.2 Pharmerging Product Type, Application and Specification

3.2.2.1 Product A

3.2.2.2 Product B

3.2.3 GlaxoSmithKline Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.2.4 Main Business/Business Overview

3.3 Pfizer

3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.3.2 Pharmerging Product Type, Application and Specification

3.3.2.1 Product A

3.3.2.2 Product B

3.3.3 Pfizer Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.3.4 Main Business/Business Overview

3.4 Sanofi

3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.4.2 Pharmerging Product Type, Application and Specification

3.4.2.1 Product A

3.4.2.2 Product B

3.4.3 Sanofi Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.4.4 Main Business/Business Overview

3.5 Novartis

3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.5.2 Pharmerging Product Type, Application and Specification

3.5.2.1 Product A

3.5.2.2 Product B

3.5.3 Novartis Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.5.4 Main Business/Business Overview

3.6 Abbott Laboratories

3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.6.2 Pharmerging Product Type, Application and Specification

3.6.2.1 Product A

3.6.2.2 Product B

3.6.3 Abbott Laboratories Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.6.4 Main Business/Business Overview

3.7 Shire

3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.7.2 Pharmerging Product Type, Application and Specification

3.7.2.1 Product A

3.7.2.2 Product B

3.7.3 Shire Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.7.4 Main Business/Business Overview

3.8 Bayer

3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.8.2 Pharmerging Product Type, Application and Specification

3.8.2.1 Product A

3.8.2.2 Product B

3.8.3 Bayer Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.8.4 Main Business/Business Overview

3.9 Biogen

3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.9.2 Pharmerging Product Type, Application and Specification

3.9.2.1 Product A

3.9.2.2 Product B

3.9.3 Biogen Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.9.4 Main Business/Business Overview

3.10 F. Hoffmann-La Roche

3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.10.2 Pharmerging Product Type, Application and Specification

3.10.2.1 Product A

3.10.2.2 Product B

3.10.3 F. Hoffmann-La Roche Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.10.4 Main Business/Business Overview

3.11 Johnson & Johnson

3.12 Mitsubishi Tanabe Pharma

3.13 Novo Nordisk

3.14 Sun Pharmaceutical

3.15 Takeda Pharma

3.16 Teva Pharmaceutical Industries

4 China Pharmerging Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)

4.1 China Pharmerging Capacity, Production and Growth (2012-2017)

4.2 China Pharmerging Revenue and Growth (2012-2017)

4.3 China Pharmerging Production, Consumption, Export and Import (2012-2017)

5 China Pharmerging Production, Revenue (Value), Price Trend by Type

5.1 China Pharmerging Production and Market Share by Type (2012-2017)

5.2 China Pharmerging Revenue and Market Share by Type (2012-2017)

5.3 China Pharmerging Price by Type (2012-2017)

5.4 China Pharmerging Production Growth by Type (2012-2017)

6 China Pharmerging Market Analysis by Application

6.1 China Pharmerging Consumption and Market Share by Application (2012-2017)

6.2 China Pharmerging Consumption Growth Rate by Application (2012-2017)

6.3 Market Drivers and Opportunities

6.3.1 Potential Application

6.3.2 Emerging Markets/Countries

7 ChinaPharmerging Market Analysis by Regions (Provinces)

7.1 China Pharmerging Production, Production Value and Price by Regions (Provinces)(2012-2017)

7.1.1 China Pharmerging Production and Market Share by Regions (Provinces)(2012-2017)

7.1.2 China Pharmerging Production Value and Market Share by Regions (Provinces)(2012-2017)

7.1.3 China Pharmerging Sales Price by Regions (Provinces)(2012-2017)

7.2 China Pharmerging Consumption by Regions (Provinces)(2012-2017)

7.3 China Pharmerging Production, Consumption, Export and Import (2012-2017)

8 Pharmerging Manufacturing Cost Analysis

8.1 Pharmerging Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Pharmerging

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Pharmerging Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Pharmerging Major Manufacturers in 2015

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 China Pharmerging Market Forecast (2017-2022)

12.1 China Pharmerging Capacity, Production, Revenue Forecast (2017-2022)

12.2 China Pharmerging Production, Import, Export and Consumption Forecast (2017-2022)

12.3 China Pharmerging Production Forecast by Type (2017-2022)

12.4 China Pharmerging Consumption Forecast by Application (2017-2022)

12.5 China Pharmerging Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)

12.5.1 China Pharmerging Production Forecast by Regions (Provinces)(2017-2022)

12.5.2 China Pharmerging Consumption Forecast by Regions (Provinces)(2017-2022)

12.5.3 China Pharmerging Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)

12.6 Pharmerging Price Forecast (2017-2022)

13 Research Findings and Conclusion

14 Appendix

Methodology

Analyst Introduction

Data Source

List of Tables and Figures

Figure Picture of Pharmerging

Figure China Production Market Share of Pharmerging by Type in 2015

Figure Product Picture of Tier 1

Table Major Manufacturers of Tier 1

Figure Product Picture of Tier 2

Table Major Manufacturers of Tier 2

Figure Product Picture of Tier 3

Table Major Manufacturers of Tier 3

Table Pharmerging Consumption Market Share by Application in 2015

Figure Lung Cancer Examples

Figure Breast Cancer Examples

Figure Chronic Myeloid Leukemia Examples

Figure Lymphomas Examples

Figure Other Examples

Figure China Pharmerging Revenue (Million USD) and Growth Rate (2012-2022)

Table China Pharmerging Capacity of Key Manufacturers (2015 and 2016)

Table China Pharmerging Capacity Market Share of Key Manufacturers (2015 and 2016)

Figure China Pharmerging Capacity of Key Manufacturers in 2015

Figure China Pharmerging Capacity of Key Manufacturers in 2016

Table China Pharmerging Production of Key Manufacturers (2015 and 2016)

Table China Pharmerging Production Share by Manufacturers (2015 and 2016)

Figure 2015 Pharmerging Production Share by Manufacturers

Figure 2016 Pharmerging Production Share by Manufacturers

Table China Pharmerging Revenue (Million USD) by Manufacturers (2015 and 2016)

Table China Pharmerging Revenue Share by Manufacturers (2015 and 2016)

Table 2015 China Pharmerging Revenue Share by Manufacturers

Table 2016 China Pharmerging Revenue Share by Manufacturers

Table China Market Pharmerging Average Price of Key Manufacturers (2015 and 2016)

Figure China Market Pharmerging Average Price of Key Manufacturers in 2015

Table Manufacturers Pharmerging Manufacturing Base Distribution and Sales Area

Table Manufacturers Pharmerging Product Type

Figure Pharmerging Market Share of Top 3 Manufacturers

Figure Pharmerging Market Share of Top 5 Manufacturers

Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table AstraZeneca Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure AstraZeneca Pharmerging Market Share (2012-2017)

Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table GlaxoSmithKline Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure GlaxoSmithKline Pharmerging Market Share (2012-2017)

Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Pfizer Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Pfizer Pharmerging Market Share (2012-2017)

Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Sanofi Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Sanofi Pharmerging Market Share (2012-2017)

Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Novartis Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Novartis Pharmerging Market Share (2012-2017)

Table Abbott Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Abbott Laboratories Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Abbott Laboratories Pharmerging Market Share (2012-2017)

Table Shire Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Shire Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Shire Pharmerging Market Share (2012-2017)

Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Bayer Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Bayer Pharmerging Market Share (2012-2017)

Table Biogen Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Biogen Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Biogen Pharmerging Market Share (2012-2017)

Table F. Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table F. Hoffmann-La Roche Pharmerging Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure F. Hoffmann-La Roche Pharmerging Market Share (2012-2017)

Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Sun Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Takeda Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Teva Pharmaceutical Industries Basic Information, Manufacturing Base, Sales Area and Its Competitors

Figure China Pharmerging Capacity, Production and Growth (2012-2017)

Figure China Pharmerging Revenue (Million USD) and Growth (2012-2017)

Table China Pharmerging Production, Consumption, Export and Import (2012-2017)

Table China Pharmerging Production by Type (2012-2017)

Table China Pharmerging Production Share by Type (2012-2017)

Figure Production Market Share of Pharmerging by Type (2012-2017)

Figure 2015 Production Market Share of Pharmerging by Type

Table China Pharmerging Revenue by Type (2012-2017)

Table China Pharmerging Revenue Share by Type (2012-2017)

Figure Production Revenue Share of Pharmerging by Type (2012-2017)

Figure 2015 Revenue Market Share of Pharmerging by Type

Table China Pharmerging Price by Type (2012-2017)

Figure China Pharmerging Production Growth by Type (2012-2017)

Table China Pharmerging Consumption by Application (2012-2017)

Table China Pharmerging Consumption Market Share by Application (2012-2017)

Figure China Pharmerging Consumption Market Share by Application in 2015

Table China Pharmerging Consumption Growth Rate by Application (2012-2017)

Figure China Pharmerging Consumption Growth Rate by Application (2012-2017)

Table China Pharmerging Production by Regions (Provinces)(2012-2017)

Table China Pharmerging Production Market Share by Regions (Provinces)(2012-2017)

Table China Pharmerging Production Value by Regions (Provinces)(2012-2017)

Table China Pharmerging Production Value Market Share by Regions (Provinces)(2012-2017)

Table China Pharmerging Sales Price by Regions (Provinces)(2012-2017)

Table China Pharmerging Consumption by Regions (Provinces)(2012-2017)

Table China Pharmerging Consumption Market Share by Regions (Provinces)(2012-2017)

Table China Pharmerging Production, Consumption, Export and Import (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Pharmerging

Figure Manufacturing Process Analysis of Pharmerging

Figure Pharmerging Industrial Chain Analysis

Table Raw Materials Sources of Pharmerging Major Manufacturers in 2015

Table Major Buyers of Pharmerging

Table Distributors/Traders List

Figure China Pharmerging Capacity, Production and Growth Rate Forecast (2017-2022)

Figure China Pharmerging Revenue and Growth Rate Forecast (2017-2022)

Table China Pharmerging Production, Import, Export and Consumption Forecast (2017-2022)

Table China Pharmerging Production Forecast by Type (2017-2022)

Table China Pharmerging Consumption Forecast by Application (2017-2022)

Table China Pharmerging Production Forecast by Regions (Provinces)(2017-2022)

Table China Pharmerging Consumption Forecast by Regions (Provinces)(2017-2022)

Table China Pharmerging Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370